FactorPad
Build a Better Process

Stock Risk Measures for Spectrum Pharmaceuticals Inc

A quantitative factor review as of September 30, 2021.
  1. Company Info - Description, identity and sector data.
  2. Share Data - Stock earnings and key dates.
  3. Market Risk - Beta, size, liquidity and momentum measures.
  4. Financial Risk - Earnings and dividends.
face pic by Paul Alan Davis, CFA
Updated: October 05, 2021
See how we arrive at an overall risk score of 90 for SPPI below.

/ factorpad.com / stocks / f14kzb.html


An ad-free and cookie-free website.


SPPI Risk Report

Overview

Our quantitative data points are meant to provide a high-level understanding of factors in equity risk models for Spectrum Pharmaceuticals Inc. Portfolio managers use these models to forecast risk, optimize portfolios and review performance.

We show how SPPI stock compares to 2,000+ US-based stocks, and to peers in the Manufacturing sector and Pharmaceutical Preparation Manufacturing industry.

Please do not consider this data as investment advice. Data is downloaded from sources we deem reliable, but errors may occur.

Company Info

Business Description

Company logo Spectrum Pharmaceuticals is a biopharmaceutical company focused on acquiring, developing, and commercializing novel and targeted oncology therapies. Spectrum has a strong track record of successfully executing across the biopharmaceutical business model, from in-licensing and acquiring differentiated drugs, clinically developing novel assets, successfully gaining regulatory approvals and commercializing in a competitive healthcare marketplace. Spectrum has a late-stage pipeline with novel assets that serve areas of unmet need. This pipeline has the potential to transform the company in the near future.

Identity

Sector and Industry

Share Data

Shares

Earnings and Dividends

Market Risk Measures

Many of the following risk metrics are standardized and transformed into quantitative factors in institutional-level risk models.

Rankings below represent percentiles from 1 to 100, with 1 being the lowest rating of risk.

Systematic Risk

Stocks with higher beta exhibit higher sensitivity to the ups and downs in the market. (↑↑)

Company Size

Stocks with higher market capitalization often have lower risk. (↑↓)

Trading Liquidity

Higher average daily dollar volume over the past 30 days implies lower liquidity risk. (↑↓)

Price Momentum

Higher price momentum stocks, aka recent winners, equate to lower risk for many investors. (↑↓)

Financial Risk Measures

Style risk factors often include measures of profitability and payout levels.

Earnings Yield

Companies with higher earnings generally provide lower risk. (↑↓)

Dividend Yield

Companies with higher dividend yields, if sustaintable, are perceived to have lower risk. (↑↓)

/ factorpad.com / stocks / f14kzb.html


SPPI stock risk
SPECTRUM PHARMACEUTICALS INC stock beta
SPPI risk report
SPPI f14kzb
SPPI risk analysis
SPPI volatility
SPECTRUM PHARMACEUTICALS INC credit risk
SPPI liquidity risk
SPPI leverage
SPPI valuation
SPPI systematic risk
SPPI specific risk
SPECTRUM PHARMACEUTICALS INC volatility
SPPI analysis
SPPI financial ratio

A newly-updated free resource. Connect and refer a friend today.